Trials / Completed
CompletedNCT01969201
FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)
Randomised Clinical Trial Comparing Highly Purified FSH Formulation (Fostimon®) and Recombinant FSH (Gonal-F®) in GnRH-antagonist Controlled Ovarian Hyperstimulation Cycles.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 710 (actual)
- Sponsor
- IBSA Institut Biochimique SA · Industry
- Sex
- Female
- Age
- 18 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the non-inferiority study is to evaluate the clinical efficacy and the safety of two different subcutaneous FSH preparations (Fostimon versus Gonal-F) for controlled ovarian hyperstimulation in a GnRH-antagonist cycle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Urofollitrophin | |
| DRUG | Follitrophin alpha |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-06-01
- Completion
- 2017-08-01
- First posted
- 2013-10-25
- Last updated
- 2019-10-09
- Results posted
- 2019-10-09
Locations
16 sites across 6 countries: Belgium, Italy, Spain, Switzerland, Turkey (Türkiye), United Kingdom
Source: ClinicalTrials.gov record NCT01969201. Inclusion in this directory is not an endorsement.